Scholz, J. K., Shumilov, E., Carobin, V., Blumenberg, V., Wisskirchen, J., Seiffert, S., Nakov, P., Chitadze, G., Riedel, A., Gagelmann, N., Holderried, T. A., Schultze-Florey, C., Fischer, M., Harrer, D., Schaefer-Eckart, K., Kharboutli, S., Mougiakakos, D., Knop, S., Hansmann, L., Dreger, P., Koenecke, C., Ayuk, F., Bethge, W., Pott, C., Vucinic, V., Drouet, E. W., Subklewe, M., Lenz, G., Voelkl, S., Mackensen, A., Müller, F. (2025). Impact of bridging therapy on efficacy of CD19 CAR T cell therapy in diffuse-large B cell lymphoma: Histology and the choice of drug matter. Blood. https://doi.org/10.1182/blood-2025-1949